| pubmed-article:14518301 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14518301 | lifeskim:mentions | umls-concept:C0699791 | lld:lifeskim |
| pubmed-article:14518301 | lifeskim:mentions | umls-concept:C0037039 | lld:lifeskim |
| pubmed-article:14518301 | lifeskim:mentions | umls-concept:C1539861 | lld:lifeskim |
| pubmed-article:14518301 | lifeskim:mentions | umls-concept:C0163611 | lld:lifeskim |
| pubmed-article:14518301 | lifeskim:mentions | umls-concept:C1539865 | lld:lifeskim |
| pubmed-article:14518301 | lifeskim:mentions | umls-concept:C2003941 | lld:lifeskim |
| pubmed-article:14518301 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
| pubmed-article:14518301 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
| pubmed-article:14518301 | pubmed:issue | Suppl I | lld:pubmed |
| pubmed-article:14518301 | pubmed:dateCreated | 2003-10-1 | lld:pubmed |
| pubmed-article:14518301 | pubmed:abstractText | The objective of this prospective study was to investigate the role of sialytransferase activities in patients with gastric cancer. In patients with gastric cancer we observed a significant correlation between sialyltransferase ST6N levels and survival after a median follow up of one year. High ST6N levels in the tumor and the surrounding normal mucosa were associated with poor prognosis. The results of this pilot study encourage further evaluation of sialyltransferase in patients with gastric cancer. | lld:pubmed |
| pubmed-article:14518301 | pubmed:language | ger | lld:pubmed |
| pubmed-article:14518301 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14518301 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14518301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14518301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14518301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14518301 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14518301 | pubmed:issn | 0942-2854 | lld:pubmed |
| pubmed-article:14518301 | pubmed:author | pubmed-author:FischerJJ | lld:pubmed |
| pubmed-article:14518301 | pubmed:author | pubmed-author:SchlagP MPM | lld:pubmed |
| pubmed-article:14518301 | pubmed:author | pubmed-author:KemmnerWW | lld:pubmed |
| pubmed-article:14518301 | pubmed:author | pubmed-author:GretschelSS | lld:pubmed |
| pubmed-article:14518301 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14518301 | pubmed:volume | 115 | lld:pubmed |
| pubmed-article:14518301 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14518301 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14518301 | pubmed:pagination | 475-8 | lld:pubmed |
| pubmed-article:14518301 | pubmed:dateRevised | 2008-2-20 | lld:pubmed |
| pubmed-article:14518301 | pubmed:meshHeading | pubmed-meshheading:14518301... | lld:pubmed |
| pubmed-article:14518301 | pubmed:meshHeading | pubmed-meshheading:14518301... | lld:pubmed |
| pubmed-article:14518301 | pubmed:meshHeading | pubmed-meshheading:14518301... | lld:pubmed |
| pubmed-article:14518301 | pubmed:meshHeading | pubmed-meshheading:14518301... | lld:pubmed |
| pubmed-article:14518301 | pubmed:meshHeading | pubmed-meshheading:14518301... | lld:pubmed |
| pubmed-article:14518301 | pubmed:meshHeading | pubmed-meshheading:14518301... | lld:pubmed |
| pubmed-article:14518301 | pubmed:meshHeading | pubmed-meshheading:14518301... | lld:pubmed |
| pubmed-article:14518301 | pubmed:meshHeading | pubmed-meshheading:14518301... | lld:pubmed |
| pubmed-article:14518301 | pubmed:meshHeading | pubmed-meshheading:14518301... | lld:pubmed |
| pubmed-article:14518301 | pubmed:meshHeading | pubmed-meshheading:14518301... | lld:pubmed |
| pubmed-article:14518301 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:14518301 | pubmed:articleTitle | [Significance of alpha 2,6-specific sialyltransferase ST6N and alpha 2,3-specific sialyltransferase ST3N in stomach carcinoma]. | lld:pubmed |
| pubmed-article:14518301 | pubmed:affiliation | Robert-Rössle Klinik, Universitätsklinikum Charité, Humboldt Universität zu Berlin, Max Delbrück-Centrum für Molekulare Medizin, Berlin. | lld:pubmed |
| pubmed-article:14518301 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14518301 | pubmed:publicationType | English Abstract | lld:pubmed |
